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Context. Americans express a strong preference for participating in decisions regarding their medical care, yet they are often
unable to participate in decision-making regarding their end-of-life care.
Objective. To examine determinants of end-of-life planning; including, the effect of an individual’s ageing and dying pro-
cess, health status and socio-economic and racial/ethnic background.
Methods. US observational cohort study, using data from the Health and Retirement Study (1992 − 2014) including 37,494
individuals. Random-effects logistic regression analysis was used to examine the relationship between the presence of a living
will and a range of individual time-varying characteristics, including time to death, and several time-invariant characteristics.
Results. End-of-life planning depends on several patient characteristics and circumstances, with socio-economic and racial/
ethnic background having the largest effects. The probability of having a living will rises sharply late in life, as we would expect,
and is further modified by the patient’s proximity to death. The dying process, exerts a stronger influence on end-of-life plan-
ning than does the aging.
Conclusions. Understanding differences that increase end-of-life planning is important to incentivize patients’ participation.
Advance planning should be encouraged and accessible to people of all ages as it is inevitable for the provision of patient-cen-
tered and cost-effective care. J Pain Symptom Manage 2021;000:1−9. © 2021 The Authors. Published by Elsevier Inc. on behalf of
American Academy of Hospice and Palliative Medicine. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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to participate in decision making related to their end-
of-life care.2 Around 70% of decedents over 60 sur-
veyed in the Health and Retirement Study (HRS) were
not able to participate in those decisions3. Additionally,
terminally ill individuals are often subjected to unde-
sired and unhelpful treatments advocated by patients’
carers or family members.4,5 This demonstrates the
importance of prospectively recording patients’ wishes
regarding intensive care in order to achieve goal-con-
cordant care.
An advance directive is a legal document describing
a patient’s preferences regarding their medical care in
case of incapacity, and is a key mechanism through
which patients express their end-of-life care wishes. In
the United States (US), this document can take two
forms, either a living will or a durable power of attor-
ney. The living will is a written statement containing
people’s preferences regarding future medical treat-
ment in situations when they can no longer provide
informed consent.1 In contrast, a durable power of
attorney gives decision-making power to a designated
person who will decide on the patient’s behalf, when
the latter is incapable of making such decision.1
Although written instructions about preferences for
end-of-life care can go by various names, we use the
term “living will” to refer to all such sets of instructions
and consider it as a form of advance care planning. Evi-
dence suggests that having an advanced directive is
associated with better quality end-of-life care.6-8
Advance care planning can empower patients and
assist physicians in providing goal-concordant care.9 In
the context of end-of-life care provision, the traditional
doctor-patient relationship becomes more complicated
as terminally ill patients may experience high levels of
dependency and frailty which can limit their sover-
eignty and exaggerate the problem of asymmetric
information.10 Information asymmetry implies that the
physician is better informed about the patient’s health
status and possible treatment pathways.11 Often family
members and carers become proxy decision-makers to
represent the patients’ interests and preferences, which
additionally complicates the decision-making process,
especially if the patient’s preferences are unrecorded.
Therefore, an advance care plan provides an opportu-
nity to align the interests of the physician and the
patient, making understanding factors that affect
advance care planning critical.9,12 Advance planning
can be viewed as a type of health behavior, for which
different individuals may have different motivation,
facilitators and barriers.13 Recently, however, scepti-
cism about the value of advance care planning is
increasing, since uptake remains low and evidence for
advance care planning influencing patient outcomes is
limited.14 Therefore, it is important to understand
determinants of advance care planning which coulddetermine the design and implementation of policies
that encourage the uptake and engagement in such
activities across various patient groups. A patient’s
prognosis or their subjective expectations regarding
the imminence of death is one factor that could
raise awareness of and encourage end-of-life plan-
ning. Thus, the aim of this paper is to examine the
impact of socio-demographic factors, health status,
age and proximity to death on advance care plan-
ning.Methods
Sample
Our analysis uses a sample of 37,494 individuals
from the Health and Retirement Study (HRS), sur-
veyed biennially from 1992 through 2014. On average,
each sample member appears about six times in the
dataset. The HRS is a nationally representative longitu-
dinal study of individuals over 50 years of age, designed
to assess retirement and health among the elderly in
the US.15 It is a rich source of data organized into four
major section: health, work and retirement, social con-
nections and income and wealth.
The surveys include “exit interviews,” questionnaires
completed by proxy respondents after a participant’s
death, identified from the social network of the
deceased. The exit interview provides detailed informa-
tion on the respondent’s final year of life and death cir-
cumstances.
The first cohort of HRS participants was interviewed
in 1992; since then five additional cohorts have been
included in the panel study in order to replenish the
study sample. Our data include any age-eligible individ-
ual interviewed at least once. The target population for
study sample initially included all US residents aged 51
− 61 who live in households, later expanded (by 1998)
to include the entire population aged 51 and older.
Following conventional practice for population surveys,
institutionalized individuals (prisons, jails, nursing
homes, long-term or dependent care facilities) are
excluded from the initial survey population, although
they are retained if in subsequent interviews they have
moved to a nursing home. Baseline interviews are con-
ducted face-to-face, while follow-up interviews are
mostly conducted via telephone. Since 2006, at each
wave, half of the respondents complete the face-to-face
while the other half complete the core interview by
telephone. The half-samples alternate waves so there is
an in-person interview for each respondent every four
years.
Analysis
The presence of a living will is our outcome measure
and it is used as an indicator of advance care planning.
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deceased had written end-of-life instructions was
included in the exit interview. Because the timing of
end-of-life instructions was included in the question-
naire, we were able to reconstruct the presence of these
for deceased participants prior to their death. For
deceased participants without written end-of-life
instructions we assumed that these were also not avail-
able at the times of previous interviews. Further, from
2012, the core HRS questionnaire included a question
regarding the presence of the living will. If a living par-
ticipant gave a negative response, then we assumed
that the participant did not have a living will in all pre-
vious waves. In contrast, if a living participant con-
firmed the existence of a living will, we coded data in
all previous waves as missing, as we were not sure when
the end-of-life instructions were written. About 33% of
deceased participants and 20% of living participants
had a living will.
Ageing was represented using both: chronological
age and remaining lifetime, with the latter serving as
proxy for biological age. As people age, they are more
aware that the end of their life is approaching. The
aging process can be characterized through chronolog-
ical age, which refers to amount of time the person has
been alive, or through biological age, which refers to
how old the person seems and which is related to
genetic, behavioral, and environmental conditions.16
Biological age can be characterized using various bio-
markers of ageing, but these are not routinely mea-
sured in population-level studies. On the other hand, if
individuals are followed longitudinally, some will die
during a follow up period. Remaining lifetime, or time
to death (TTD) can be used as a proxy for biological
age.17 Research has shown that individuals’ expecta-
tions regarding their own future survival agree with
actual experience, demonstrating that biomarkers
were predictive of TTD regardless of age.18−21 The
idea of using TTD in describing patients trajectories
first appeared in 1970s and focused on hospital care of
terminally ill patients.22 Later, few other studies consid-
ered TTD in assessing disability and classifying dying
patients.17,23 Despite that, most studies take into
account only chronological age, while ignoring the
impact of TTD on late life events.
A problem with TTD in panel studies is that for liv-
ing participants it remains unknown, because only in
rare occasions the sample will be followed up until all
individuals die, removing the right-censoring prob-
lem.17 Still, it can be estimated. Information on partici-
pants’ month and year of birth, death (if applicable),
and month and year of interviews was used to establish
measures of age and TTD at each interview. All age var-
iables were expressed relative to age 75. For those who
died during the follow up period, TTD is known and
can never exceed 22 years. Participants that remainalive at the end of the follow up period have an unob-
served value of TTD at each interview. We used interval
regression to model remaining lifetime and to provide
a basis for imputing the unobserved (censored) values
of TTD. For cases with unknown a value of TTD, we
constructed variables for lower and upper bounds of
TTD. For cases with censored TTD, the lower bound of
TTD is always known. For example, for someone still
alive in 2014, we know that TTD is greater than 22 in
1992, and TTD is greater than 20 in 1994, and so on.
So, at each interview the lower bound of TTD presents
a difference between the age at final interview and the
age at the current interview. We also assumed that the
maximum possible age of participant is 112 years, as
this was the age of the oldest deceased participant in
the sample. The upper bound of TTD at each wave is
defined as the difference between the maximum possi-
ble age and the current age of participant at each inter-
view. Our interval regression for remaining lifetime
imposes these bounds; when TTD is known (among
uncensored cases) the upper and lower bounds are
identical. Explanatory variables used in the regression
include age, gender, indicator for racial and ethnicity
status (Non-Hispanic White, Non-Hispanic Black, His-
panic White and Other), education level (below high-
school level, high-school level, degree level), total
assets, marital status (married or partnered, not-mar-
ried or not-partnered), smoking and drinking status,
self-reported health, census region (Midwest, North-
west, South, East and Other), and indicators for the fol-
lowing medical conditions: high blood pressure,
diabetes, cancer, lung disease, heart disease, stroke,
arthritis and psychiatric problems. These conditions
are the most common comorbidities among the
elderly.24 The estimated regression was used to impute
TTD to the censored observations, with the known
lower- and upper-bound conditions imposed. Because
we are using a linear model of remaining lifetime, it
produces an unbiased estimate of the expected value
of remaining lifetime among those for whom TTD is
not observed.
We used random-effects logistic regression to esti-
mate the relationship between the probability of having
a living will and a set of time-varying and time-invariant
control variables. To account for the uncertainty pres-
ent in the TTD imputation process, we performed five
independent sets of imputations, and used multiple
imputation estimation and inference techniques in the
analysis. Explanatory variables included age and TTD
in linear and quadratic form, gender, indicator for
racial and ethnicity status, education level, marital sta-
tus, income and assets, census region, and indicators
for excellent self-reported health (health status is very
good or excellent), and the presence of the eight medi-
cal conditions listed above. All analyses were performed









TTD (imputed) 16.32 6.16
TTD (observed) 7.16 5.01
Income
Total income $67,853 $162.17 (S.E.)a
Missing 6.70%
Assets






































Non-Latino White 72.83% -
Non-Latino Black 15.89% -
Latino White 7.45% -
Other race/ethnicity 3.83% -
Missing 0.00% -
Cohabitation status
Living with partner 63.39% -
Not living with partner 34.27% -
Missing 2.34% -
Education
Lower than high school level 26.73% -
High school level 51.57% -
Graduate level 21.60% -
Missing 0.10%
Region
Northeast region 16.01% -
Midwest region 24.09% -
South region 40.49% -
West region 12.27% -
Other region 0.14% -
Missing 0.00% -
TTD denotes = time-to-death, ADL = activities of daily living.
aS.E. denotes standard error. Variables “Total income” and “Total assets” are
highly skewed, so standard error is a more appropriate measure of dispersion.
The values are averaged over the pooled sample of 37,494 individuals and
226,545 person-wave observations.
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On average, individuals were 66 years old over the 12
survey waves (Table 1). Average estimated TTD for the
analyzed sample was 16.3 years, while average observed
TTD for individuals with observed deaths was 7.2 years.
Majorities of the sample were non-Hispanic Whites
(72.8%), female (60.3%) and had a high-school degree
or more (73.2%). Arthritis was the most common
chronic condition reported by 49.3% of participants,
while stroke was the least common condition, reported
by only 5.7% of the sample. Table 1
A range of individual characteristics affected the
presence of the living will (Table 2). Age [OR (Age)
=1.85, 95%CI (1.81 − 1.90), P<0.001; OR (Age^2)
=0.99, 95%CI (0.986 − 0.988), P<0.001], TTD [OR
(TTD)=0.73, 95%CI (0.69 − 0.76), P<0.001; OR
(TTD^2)=1.01, 95%CI (1.008 − 1.012), P<0.001] and
racial and ethnic background [OR (Non-Latino Black)
= 0.002, 95%CI (0.002 − 0.004), P<0.001; (OR (Latino
White)= 0.002, 95%CI (0.001 − 0.005), P<0.001] are
significantly associated the probability of having a living
will. Non-Hispanic Whites had significantly higher
probability of engaging in end-of-life planning activi-
ties, compared to individuals of other racial and ethnic
background. Moreover both educational attainment
[OR (High school level)=30.49, 95%CI (19.3 − 48.1),
P<0.001; OR (Graduate level)=165.2, 95%CI (103.3 −
264.2), P<0.001] and economic well-being [OR (Line-
arized income)=1.65, 95%CI (1.47 − 1.85), P<0.001],
were important factors in having a living will. In gen-
eral, individuals of higher social status were more likely
to have a living will. Also, the probability was higher for
individuals of poorer health [OR(Difficulties with
ADLs)=1.42, 95%CI (1.32 − 1.53), P<0.001] and
females [OR=3.41, 95%CI (2.42 − 4.78), P <0.001], but
lower for those living with a partner [OR=0.45, 95%CI
(0.35 − 0.59), P <0.001]. Cancer [OR=1.77, 95%CI
(1.46 − 2.14), P <0.001] in particular had a strong
effect on the probability on having a living will. Other
chronic conditions such as high-blood pressure
[OR=1.20, 95%CI (1.06 − 1.34), P =0.004], lung disease
[OR=1.20, 95%CI (1.01 − 1.41), P =0.034] were also
associated with having a living will. However, the pres-
ence of diabetes, stroke and psychiatric problems were
not associated with having a living will. Table 2
As individual end-of-life planning trajectories
depend both on age and TTD, there are numerous
pathways in progress within the general population at
any moment. We illustrate selected scenarios in Fig. 1
and show how they are modified by various background
factors in Figs. 2 and 3. In all cases, the fitted probabili-
ties reflect the mix of sample characteristics in all other
respects. Fig. 1 illustrates the pattern of having a living
will for individuals who die at age 80, 90 and 100,
depending on current age. Individuals who die at a
Table 2
Random-Effects Logistic Regression Analysis of Determinants of Planning at the End-of-Life
Independent Variable (N= 33,172) Presence of the Living
Will Odds Ratios (95% CI)
P Value
Intercept 0.010 (0.000 − 0.020) <0.001***
TTD 0.725 (0.693 − 0.758) <0.001***
TTD^2 1.010 (1.008 − 1.012) <0.001***
Age 1.853 (1.808 − 1.899) <0.001***
Age^2 0.987 (0.986 − 0.988) <0.001***
Gender (Ref: Male) 3.410 (2.431 − 4.782) <0.001***
Race/ethnicity (Ref: Non-Latino White)
Non-Latino Black 0.002(0.002 − 0.004) <0.001***
Latino White 0.002 (0.001 − 0.005) <0.001***
Other 0.004 (0.001 − 0.012) <0.001***
Living with partner 0.452 (0.348 − 0.589) <0.001***
Linearized total income 1.647 (1.469 − 1.847) <0.001***
Total assets 1.003 (1.002 − 1.004) <0.001***
Education level (Ref: Lower than high school level)
High school level 30.487 (19.330 − 48.083) <0.001***
Graduate level 165.181 (103.276 − 264.191) <0.001***
High blood pressure 1.199 (1.060 − 1.355) 0.004**
Diabetes 1.143 (0.966 − 1.353) 0.119
Cancer 1.766 (1.458 − 2.139) <0.001***
Lung disease 1.195 (1.013 − 1.409) 0.034**
Heart disease 0.902 (0.808 − 1.008) 0.068*
Stroke 1.071 (0.883 − 1.299) 0.487
Psychiatric problems 1.094 (0.957 − 1.251) 0.190
Arthritis 1.113 (0.988 − 1.254) 0.078*
Number of difficulties with ADLs 1.421 (1.320 − 1.530) <0.001***
Self-reported health excellent (Ref: Self-reported health is below excellent) 0.945 (0.790 − 1.129) 0.532
Region (Ref: North-east)
Midwest 2.491 (1.541 − 4.027) <0.001***
South 1.205 (0.780 − 1.861) 0.400
West 4.545 (2.643 − 7.815) <0.001***
Other 0.950 (0.028 − 32.388) 0.977
Notes: Presented results are from random effects logistic regression analysis. Results are presented as odds ratios. Odds ratio indicates percentage odds change for a
unit increase in the observed variable, holding other variables constant. For categorical variables, the reference category is stated in the row label, otherwise the ref-
erence is the complementary category. Total income values and total asset values were divided by 100,000 to aid interpretation.
*P<0.1
**P<0.05
***P<0.001. N denotes sample size.
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living will immediately prior to death (97.5%), while
the analogous probability for individuals who die at age
80 is much lower (38.1%). Lastly, most individuals
don’t initiate a living will until age 75 or older. Fig. 1
Non-Hispanic Whites initiate end-of-life planning
much earlier compared to those of other ethnic and
racial backgrounds, and also end up with much
higher levels or participation (Fig. 2). For example,
Non-Hispanic Whites dying at age 100 will almost
certainly have a living will (99.2%), while the same
probability among Non-Hispanic Blacks dying at the
same age is much lower (37.5%). The differences
are even larger for individuals who die younger,
indicating the importance of ethnicity and race for
end-of-life planning. Fig. 2
More educated individuals are more likely to partici-
pate in end-of-life planning and, on average, do so ear-
lier compared to their less-educated counterparts
(Fig. 3). The differences are particularly high for indi-
viduals who die younger. For example, a college-edu-
cated individual who dies at age 80 years has 79.1%probability of having a living will, while someone with
only a basic education dying at the same age has only a
2.4% probability of having a living will. Fig. 3Discussion
The study provides insights into factors that affect
advance care planning. Our results, based on a nation-
ally representative sample of Americans, provide key
insights into factors that indicate variation in how and
when Americans perform advance care planning. We
show that despite concerted efforts to push advance
care planning upstream, few individuals undertake
advance care planning before the age of 75, and only
about a third of patients who die at age 80 adopt an
advance care plan. Furthermore, while patients with
cancer are most likely to have an advance care plan,
patients with heart disease, the most common cause of
death in the US, are least likely to have an advance care
plan.
Our results provide unique insights into how biologi-












65 67 69 71 73 75 77 79 81 83 85 87 89 91 93 95 97 99
Current age
Death at age 100
Death at age 90
Death at age 80
Fig. 1. Probability of having a living will, by current age and age at death. Notes: The graph depicts an average sample popula-
tion for different ages at death. For interpretation of the references to color in this figure legend, the reader is referred to the
web version of this article.
Fig. 2. Probability of having a living will, by current age and age at death for individuals of different ethnical and racial back-
ground. Notes: The graph depicts an average sample population of different ethnical and racial background for different ages
at death. Effect of Non-Latino Black is similar to the effect of Latino White and therefore trajectories of Non-Latino Black are
indicative of those of Latino White. For interpretation of the references to color in this figure legend, the reader is referred to
the web version of this article.
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65 67 69 71 73 75 77 79 81 83 85 87 89 91 93 95 97 99
Current age
Death at age 100, Lower than HS level
Death at age 90, Lower than HS level
Death at age 80, Lower than HS level
Death at age 100, Graduate level
Death at age 90, Graduate level
Death at age 80. Graduate level
Fig. 3. Probability of having a living will, by current age and age at death for different educational levels. Notes: HS denotes
“high-school”. The graph depicts an average sample population that has different levels of educational attainment for different
ages at death. For interpretation of the references to color in this figure legend, the reader is referred to the web version of this
article.
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age, our results indicate that it is chronological age,
and not biological age, that exerts a stronger influence
on the likelihood of having a living will.17 Further, wors-
ened health status is also positively correlated with par-
ticipation in end-of-life planning. However, even
though aging and health status matter, an individual’s
socio-economic and racial/ethnic circumstances
appear to have a strong association with the propensity
to plan for the end-of-life. Non-Hispanic Whites and
more educated Americans have considerably higher
rates of end-of-life planning participation.
Serious illnesses significantly increase someone’s
likelihood of having a living will though not all diseases
have a similar impact. A cancer diagnosis is often pre-
sented to a patient as a “death sentence,” and may be
accompanied by a prognosis regarding remaining life-
time likely prompting patents without living wills to
consider adopting one. Additionally, as cancer patients
tend to have better access to palliative services, they
may also have a better awareness of end-of-life planning
options and their significance.25 However, patients with
heart disease, the most common cause of death in the
US, are least likely to have an advance care plan, sug-
gesting opportunities to improve care and communica-
tion for this large group of patients. Prior work has
shown that both patients with heart disease and theirphysicians are likely to underestimate their risk of mor-
tality compared to cancer, which could reduce their
likelihood of documenting an advance care plan since
it alters their perceived time to death.26,27
Our results are consistent with recent studies on
end-of-life planning.28,29 Older individuals and those in
poorer health are more aware that death is approach-
ing and are more inclined to engage in care planning
activities that could relieve pain and discomfort in their
last moments of life.1 However, few studies consider
both age and remaining lifetime simultaneously, sug-
gesting that the dying process is more influential than
aging process as a determinant of end-of-life plan-
ning.17 Our results suggest that proximity to death, and
not just chronological age, is one of the strongest driv-
ers of health care utilization at the end-of-life.30,31
Having an advance care plan affects patient out-
comes. Individuals with recorded end-of-life preferen-
ces are less likely to utilize intensive, out-of-hospital
institutional care at end of their lives.32 Evidence also
suggests that having an advance plan increases the like-
lihood of fulfilling the patients' preferences regarding
their end-of-life care8 and improves their satisfaction
and quality of life in their final weeks of life.7 End-of-
life planning may help to align the interests and mini-
mize disputes between the principal (patient) and the
agent (physician). It can prevent overutilization, and
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that resources are used in more cost-effective ways.33
In the US, advance care planning has been widely
promoted as a tool for communicating end-of-life pref-
erences.34 Despite these efforts, completion rates
remain low. According to a recent systematic review,
only about one third of Americans has completed
some form of advance care planning.34 Since 2016
Medicare reimburses physicians for having end-of-life
conversations, and early evidence suggests that these
conversations are associated with less intensive end-of-
life care.35 Also, advance care planning includes several
legal conditions, required for executing advance direc-
tives, such as qualified witnesses and notarization.34
Even though these restrictions are put in place to pro-
tect the patients, these can also be barriers for those
that might not fully understand the legal system and
cannot afford legal counselling.
This study has several limitations. The analysis uti-
lizes exit interviews which are conducted with a proxy
respondent, which might lead to missing or erroneous
information regarding the existence and content of liv-
ing wills. Nevertheless, most proxy-respondents (88%)
are close family members and they are likely aware of
care planning activities of their loved ones. Further,
family and health care professionals may have an
important role in individual’s end-of-life decision-mak-
ing, but unfortunately the used data does not allow
investigations of their impact to end-of-life decisions
and living will content. Also, it was not possible to assess
the patient's quality of end-of-life or family satisfaction
with the patient death quality and to investigate the
relationship between having a living will and the end-
of-life care model (e.g. ICU or palliative care). Another
potential weakness is the imputation of TTD. While we
used an extensive set of possible predictors, we cannot
exclude a possibility of unobserved heterogeneity that
could bias our estimates. Finally, even though our ran-
dom-effects logistic model controls for a wide range of
individual characteristics that may affect advance care
planning, some important determinants might remain
unobserved. Therefore, our findings should be inter-
preted as associations and not as causal effects.
Advance care planning is an important step for the
provision of patient-centred and cost-effective care.36
Since the US is racially and ethnically diverse, initiatives
should also be culturally tailored to acknowledge differ-
ent attitudes and motivation towards advance planning.
In addition, advance care planning can serve as an
instrument to accelerate a change in attitudes towards
death and dying, moving away from traditional medical
paternalism.37 Also, this can assist in reducing informa-
tion asymmetry in the doctor-patient relationship and
facilitate informed decision-making. Planning for the
end-of-life can have a significant effect on the carepatients receive in their last moments.3 Policies should
be aimed not only at patients and healthcare professio-
nals, but also at close family members and caregivers to
incentivize patients to express and record their end-of-
life preferences. This may reduce decision-making con-
flicts and minimize the risk of overtreatment as well as
the provision of unwanted and futile care. It can also
contribute to a more rational use of scarce healthcare
resources and lower societal burden.
Patient autonomy is increasingly becoming a central
ethical principle in healthcare decision-making. Policy
makers need to favor policies that empower patients
and increase their participation in advance care plan-
ning. These policies should be aimed at patients of all
ages, not only to older adults, as proximity to death
and not just chronological age is an important factor in
end-of-life planning.Conclusion
This study presents robust findings on the factors
affecting advance care planning in the US and suggests
that planning depends on a range of patient character-
istics and circumstances, with socio-economic and
racial/ethnic background, TTD and health status
being the most significant ones. The chances of having
a living will rise sharply late in life, as we would expect,
but are further modified by the patient’s proximity to
death. Providing the right care, at the right moment,
and according to patients’ preferences is the ultimate
goal of high-quality end-of-life care and advance care
planning is a step forward in the achievement of that
goal.Disclosures and Acknowledgments
The authors have no financial or any other kind of
personal conflicts with this paper.
This research did not receive any specific grant from
funding agencies in the public, commercial, or not-for-
profit sectors. Work by Douglas Wolf was supported by
the grant (No. P30AG066583) from the U.S. National
Institute on Aging.References
1. Institute of Medicine (US). Committee on approaching
death: Addressing key end-of-life issues. Dying in America:
improving quality and honoring individual preferences near
the end of life. Washington, D.C.: National Academies Press;
2015.
2. Nelson JE, Angus DC, Weissfeld LA, et al. End-of-life care
for the critically ill: a national intensive care unit survey. Crit
Care Med 2006;34:2547–2553.
ARTICLE IN PRESS
Vol. 00 No. 00 xxx 2021 9End-of-Life Planning3. Silveira MJ, Kim SYH, Langa KM. Advance directives and
outcomes of surrogate decision making before death. N Engl
J Med 2010;362:1211–1218.
4. Wright AA, Keating NL, Ayanian JZ, et al. Family perspec-
tives on aggressive cancer care near the end of life. JAMA
2016;315:284–292.
5. Hughes-Hallett T, Cleary J, Grant L, Harding R, Jadad A.
Dying healed: transforming end-of-life care through innova-
tion. World Innovation Summit for Health, Qatar 2013: 3.
Available at: http://www.fileserver.idpc.net/library/
27425_WISH_End_of_Life_web.pdf. Accessed July 5, 2021.
6. Teno JM, Gruneir A, Schwartz Z, Nanda A, Wetle T. Asso-
ciation between advance directives and quality of end-of-life
care: a national study. J Am Geriatr Soc 2007;55:189–194.
7. Zhang B, Wright AA, Huskamp HA, et al. Health care
costs in the last week of life: associations with end-of-life con-
versations. Arch Intern Med 2009;169:480–488.
8. Mack JW, Weeks JC, Wright AA, Block SD, Prigerson HG.
End-of-life discussions, goal attainment, and distress at the
end of life: predictors and outcomes of receipt of care consis-
tent with preferences. J Clin Oncol 2010;28:1203–1208.
9. Silveira MJ, Wiitala W, Piette J. Advance directive comple-
tion by elderly Americans: a decade of change. J Am Geriatr
Soc 2014;62:706–710.
10. Eika KH, Kjølsrød L. The difference in principle between
the poorly informed and the powerless: a call for contestable
authority. Nordic Soc Work Res 2013;3:78–93.
11. Arrow KJ. Uncertainty and the welfare economics of
medical care. Am Econ Rev 1963;53:941–973.
12. Nicholas LH, Langa KM, Iwashyna TJ, Weir DR. Regional
variation in the association between advance directives and
end-of-life medicare expenditures. JAMA 2011;306:1447–1453.
13. Fried TR, Redding CA, Robbins ML, et al. Stages of
change for the component behaviors of advance care plan-
ning. J Am Geriatr Soc 2010;58:2329–2336.
14. Sean Morrison R. Advance directives/care planning:
clear, simple, and wrong. J Palliat Med 2020;23:878–879.
15. Bugliari D, Campbell N, Chan C, et al. RAND HRS data
documentation, version P. social security administration. Natl
Inst Aging 2016.
16. Couoh LR. Differences between biological and chrono-
logical age-at-death in human skeletal remains: a change of
perspective. Am J Phys Anthropol 2017;163:671–695.
17. Wolf DA, Freedman VA, Ondrich JI, Seplaki CL, Spill-
man BC. Disability trajectories at the end of life: a "count-
down" model. J Gerontol Ser B-Psychol Sci Soc Sci
2015;70:745–752.
18. Butler RN, Sprott R, Warner H, et al. Biomarkers of
aging: from primitive organisms to humans. J Gerontol A Biol
Sci Med Sci 2004;59:B560–B567.
19. Goldman N, Turra CM, Glei DA, et al. Predicting mortal-
ity from clinical and nonclinical biomarkers. J Gerontol A
Biol Sci Med Sci 2006;61:1070–1074.
20. Levine ME. Modeling the rate of senescence: can esti-
mated biological age predict mortality more accurately than
chronological age? J Gerontol A Biol Sci Med Sci
2013;68:667–674.21. McGarry KM. Perceptions of mortality: individual assess-
ments of longevity risk.. Wharton Pension Research Council
Working Paper 2020(2020-09). Available at: https://www.
repository.upenn.edu/cgi/viewcontent.cgi?article=1680&-
context=prc_papers. Accessed July 5, 2021.
22. Glaser BG, Strauss AL. Time for dying. AldineTransac-
tion, Chicago, IL 1968.
23. Lunney JR, Lynn J, Foley DJ, Lipson S, Guralnik JM. Pat-
terns of functional decline at the end of life. JAMA
2003;289:2387–2392.
24. Diederichs C, Berger K, Bartels DB. The measurement of
multiple chronic diseases−a systematic review on existing
multimorbidity indices. J Gerontol A Biol Sci Med Sci
2011;66:301–311.
25. Hawley P. Barriers to access to palliative care. Palliat Care
2017;10:1178224216688887.
26. Allen LA, Yager JE, Funk MJ, et al. Discordance between
patient-predicted and model-predicted life expectancy
among ambulatory patients with heart failure. JAMA
2008;299:2533–2542.
27. Warraich HJ, Allen LA, Mukamal KJ, Ship A, Kociol RD.
Accuracy of physician prognosis in heart failure and lung can-
cer: comparison between physician estimates and model pre-
dicted survival. Palliat Med 2016;30:684–689.
28. McAfee CA, Jordan TR, Sheu JJ, Dake JA, Kopp Miller
BA. Predicting racial and ethnic disparities in advance care
planning using the integrated behavioral model. OMEGA-J
DEATH DYING 2017;78:369–389.
29. Lovell A, Yates P. Advance care planning in palliative care:
a systematic literature review of the contextual factors influenc-
ing its uptake 2008-2012. Palliat Med 2014;28:1026–1035.
30. Zweifel P, Felder S, Meiers M. Ageing of population and
health care expenditure: a red herring? Health Econ
1999;8:485–496.
31. Hazra NC, Rudisill C, Gulliford MC. Determinants of
health care costs in the senior elderly: age, comorbidity,
impairment, or proximity to death? Eur J Health Econ
2018;19:831–842.
32. Degenholtz HB, Rhee Y, Arnold RM. Brief communica-
tion: the relationship between having a living will and dying
in place. Ann Intern Med 2004;141:113–117.
33. Noah BA, Feigenson NR. Avoiding overtreatment at the
end of life: physician-patient communication and truly
informed consent. Pace L. Rev. 2015;36:736.
34. Yadav KN, Gabler NB, Cooney E, et al. Approximately
one in three US adults completes any type of advance direc-
tive for end-of-life care. Health Aff 2017;36:1244–1251.
35. Gupta A, Jin G, Reich A, et al. Association of billed
advance care planning with end-of-life care intensity for 2017
medicare decedents. J Am Geriatr Soc 2020;68(9):1947–1953.
36. Boerner K, Carr D, Moorman S. Family relationships and
advance care planning: do supportive and critical relations
encourage or hinder planning? J Gerontol B Psychol Sci Soc
Sci 2013;68:246–256.
37. Simon-Lorda P, Tamayo-Velazquez MI, Barrio-
Cantalejo IM. Advance directives in Spain. Perspectives from
a medical bioethicist approach. Bioethics 2008;22:346–354.
